FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2049209548> ?p ?o ?g. }

• W2049209548 endingPage "272" @default.
• W2049209548 startingPage "265" @default.
• W2049209548 abstract "The last several years have witnessed exciting progress in the development of immunotherapy for the treatment of cancer. This has been due in great part to the development of so-called checkpoint blockade. That is, antibodies that block inhibitory receptors such as CTLA-4 and PD-1 and thus unleash antigen-specific immune responses against tumors. It is clear that tumors evade the immune response by usurping pathways that play a role in negatively regulating normal immune responses. In this regard, adenosine in the immune microenvironment leading to the activation of the A2a receptor has been shown to represent one such negative feedback loop. Indeed, the tumor microenvironment has relatively high concentrations of adenosine. To this end, blocking A2a receptor activation has the potential to markedly enhance anti-tumor immunity in mouse models. This review will present data demonstrating the ability of A2a receptor blockade to enhance tumor vaccines, checkpoint blockade and adoptive T cell therapy. Also, as several recent studies have demonstrated that under certain conditions A2a receptor blockade can enhance tumor progression, we will also explore the complexities of adenosine signaling in the immune response. Despite important nuances to the A2a receptor pathway that require further elucidation, studies to date strongly support the development of A2a receptor antagonists (some of which have already been tested in phase III clinical trials for Parkinson Disease) as novel modalities in the immunotherapy armamentarium." @default.
• W2049209548 created "2016-06-24" @default.
• W2049209548 creator A5027585674 @default.
• W2049209548 creator A5040164728 @default.
• W2049209548 creator A5078875218 @default.
• W2049209548 date "2015-01-01" @default.
• W2049209548 modified "2023-10-15" @default.
• W2049209548 title "A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy" @default.
• W2049209548 cites W1513558382 @default.
• W2049209548 cites W1521173359 @default.
• W2049209548 cites W1536831250 @default.
• W2049209548 cites W1538902372 @default.
• W2049209548 cites W1546479459 @default.
• W2049209548 cites W1564075285 @default.
• W2049209548 cites W1580410057 @default.
• W2049209548 cites W1606500885 @default.
• W2049209548 cites W1675343160 @default.
• W2049209548 cites W1815757713 @default.
• W2049209548 cites W1893566975 @default.
• W2049209548 cites W1971422121 @default.
• W2049209548 cites W1977187462 @default.
• W2049209548 cites W1979412100 @default.
• W2049209548 cites W1980760876 @default.
• W2049209548 cites W1981056823 @default.
• W2049209548 cites W1981552113 @default.
• W2049209548 cites W1984727851 @default.
• W2049209548 cites W1990113288 @default.
• W2049209548 cites W1991505853 @default.
• W2049209548 cites W1992786201 @default.
• W2049209548 cites W1994969460 @default.
• W2049209548 cites W2001312442 @default.
• W2049209548 cites W2003209941 @default.
• W2049209548 cites W2003483275 @default.
• W2049209548 cites W2003598902 @default.
• W2049209548 cites W2015085911 @default.
• W2049209548 cites W2016732129 @default.
• W2049209548 cites W2016983859 @default.
• W2049209548 cites W2017712207 @default.
• W2049209548 cites W2030272844 @default.
• W2049209548 cites W2031659092 @default.
• W2049209548 cites W2034638444 @default.
• W2049209548 cites W2037673105 @default.
• W2049209548 cites W2044588680 @default.
• W2049209548 cites W2044767394 @default.
• W2049209548 cites W2046242970 @default.
• W2049209548 cites W2049601932 @default.
• W2049209548 cites W2051625512 @default.
• W2049209548 cites W2051907439 @default.
• W2049209548 cites W2053353274 @default.
• W2049209548 cites W2053908301 @default.
• W2049209548 cites W2057977955 @default.
• W2049209548 cites W2058026592 @default.
• W2049209548 cites W2059409197 @default.
• W2049209548 cites W2061071534 @default.
• W2049209548 cites W2062761137 @default.
• W2049209548 cites W2066671159 @default.
• W2049209548 cites W2069416977 @default.
• W2049209548 cites W2076067786 @default.
• W2049209548 cites W2076301973 @default.
• W2049209548 cites W2076507320 @default.
• W2049209548 cites W2077703512 @default.
• W2049209548 cites W2077971241 @default.
• W2049209548 cites W2086350471 @default.
• W2049209548 cites W2086437277 @default.
• W2049209548 cites W2086809028 @default.
• W2049209548 cites W2087013294 @default.
• W2049209548 cites W2092681867 @default.
• W2049209548 cites W2094366129 @default.
• W2049209548 cites W2097995306 @default.
• W2049209548 cites W2098414192 @default.
• W2049209548 cites W2101653483 @default.
• W2049209548 cites W2104707233 @default.
• W2049209548 cites W2105396178 @default.
• W2049209548 cites W2106190040 @default.
• W2049209548 cites W2113661022 @default.
• W2049209548 cites W2113661339 @default.
• W2049209548 cites W2120426523 @default.
• W2049209548 cites W2121770645 @default.
• W2049209548 cites W2123363005 @default.
• W2049209548 cites W2123424099 @default.
• W2049209548 cites W2129667982 @default.
• W2049209548 cites W2130229601 @default.
• W2049209548 cites W2130826590 @default.
• W2049209548 cites W2134245211 @default.
• W2049209548 cites W2137922309 @default.
• W2049209548 cites W2138905083 @default.
• W2049209548 cites W2139233991 @default.
• W2049209548 cites W2139324205 @default.
• W2049209548 cites W2139727788 @default.
• W2049209548 cites W2140875987 @default.
• W2049209548 cites W2144122564 @default.
• W2049209548 cites W2144174481 @default.
• W2049209548 cites W2145142784 @default.
• W2049209548 cites W2155081123 @default.
• W2049209548 cites W2155464214 @default.
• W2049209548 cites W2158029079 @default.
• W2049209548 cites W2158862722 @default.
• W2049209548 cites W2159502634 @default.

• next